Clinical Laserthermia Systems AB OMXSTO:CLS_B:
RAISES SEK 20.9 MILLION THROUGH FULL SUBSCRIPTION OF WARRANTS OF SERIES TO 8 B
CLS Raises SEK 20.9 Mln Through Full Subscription Of Warrants
Clinical Laserthermia Systems AB on 6ix
Earlier from Clinical Laserthermia Systems
- CLS_B: Record Q2 sales and improved margins drive narrowed losses and strong growth outlook
- CLS_B: Revenue up 43% and operating loss halved as CLS accelerates neurosurgery commercialization
- CLS_B: CLS doubled sales, improved margins, and refocused on neurosurgery for high-margin growth
- CLS_B: CLS accelerates neurosurgery growth, narrows losses, and targets profitability by 2026
- CLS_B: Revenue quadrupled and losses narrowed as neurosurgery focus and US expansion accelerated
Later from Clinical Laserthermia Systems
- Clinical Laserthermia Systems AB: Quarterly Trading Report 2025 Q3
- CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results
- Clinical Laserthermia Systems Q3 Revenue SEK 2.8 Mln
- CLS Initiates Recruitment Process For Permanent Chief Financial Officer
- Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026
Follow Clinical Laserthermia Systems into a list and get an email when it puts out news.
Follow Clinical Laserthermia Systems